全文获取类型
收费全文 | 12392篇 |
免费 | 1377篇 |
国内免费 | 260篇 |
学科分类
医药卫生 | 14029篇 |
出版年
2024年 | 31篇 |
2023年 | 235篇 |
2022年 | 311篇 |
2021年 | 447篇 |
2020年 | 586篇 |
2019年 | 610篇 |
2018年 | 537篇 |
2017年 | 502篇 |
2016年 | 440篇 |
2015年 | 398篇 |
2014年 | 675篇 |
2013年 | 774篇 |
2012年 | 573篇 |
2011年 | 683篇 |
2010年 | 534篇 |
2009年 | 514篇 |
2008年 | 502篇 |
2007年 | 528篇 |
2006年 | 533篇 |
2005年 | 516篇 |
2004年 | 416篇 |
2003年 | 363篇 |
2002年 | 332篇 |
2001年 | 254篇 |
2000年 | 239篇 |
1999年 | 211篇 |
1998年 | 235篇 |
1997年 | 205篇 |
1996年 | 177篇 |
1995年 | 156篇 |
1994年 | 149篇 |
1993年 | 154篇 |
1992年 | 120篇 |
1991年 | 113篇 |
1990年 | 78篇 |
1989年 | 90篇 |
1988年 | 82篇 |
1987年 | 66篇 |
1986年 | 73篇 |
1985年 | 96篇 |
1984年 | 91篇 |
1983年 | 69篇 |
1982年 | 67篇 |
1981年 | 50篇 |
1980年 | 56篇 |
1979年 | 41篇 |
1978年 | 25篇 |
1977年 | 19篇 |
1976年 | 22篇 |
1975年 | 13篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
71.
先天性软骨发育不全成纤维细胞生长因子受体3基因1138位核苷酸点突变的检测 总被引:5,自引:1,他引:5
目的 验证成纤维细胞生长因子受体3(fibroblast growth factor receptor 3,FGFR3)跨膜区1138位核苷酸为先天性软骨发育不全突变热点及用变性梯度电泳方法筛查的效果。方法 对17例临床诊断为先天性软骨发育不全患者进行基因组DNA聚合酶链反应-限制性酶切片段长度多态性(polymerase chain reaction-restriction fragment length polymorphism,PCR-RFLP)分析,并用变性梯度凝胶电泳(denaturing gradient gel electrophoresis,DGGE)进行其它突变位点的筛查。结果 17例患者中14例RFLP检测显示能被Sfc I酶切,提示存在1138位核苷酸G→A的转换,且均为杂合子。17例用Msp I酶切均阴性,提示无G→C的颠换。DGGE方法的筛查中,酶切阳性的14例标本均显示存在杂合型突变。3例PCR-RFLP检测阴性的标本未显示突变位点,提示在该扩增区域确实不存在突变位点。结论 FGFR3跨膜区1138核苷酸G→A的突变是软骨发育不全的主要发病机理,DGGE可作为筛查某一区域基因突变的敏感而可靠的检测手段,尤其是对杂合子的检测。 相似文献
72.
73.
Mark J. Roth MD L.Jeffrey Medeiros MD Sudesh Kapur MD Leonard H. Wexler MD Sharon Mims BS Marc E. Horowitz MD Maria Tsokos MD 《Human pathology》1993,24(12)
We describe an infant girl, born with a pigmented giant nevus, who developed a malignant schwannoma in the retroperitoneum at 16 months of age. At birth the nevus covered over 50% of her body and histologically was a compound nevus with extension into the deep dermis surrounding dermal appendages. The malignant schwannoma was biphasic with areas composed of spindle and round cells. Ultrastructurally, the majority of the tumor cells exhibited a Schwann cell phenotype, but neuroepithelial and melanocytic cells were identified as well. We believe that this constellation of findings represents a form of neurocristopathy. Neurocristopathy, as defined by Bolande (Hum Pathol 5:409–429, 1974), is a disease that results from aberrations in the migration, growth, or cytodifferentiation of neural crest tissues. These diseases may be simple (a singular pathologic process, usually localized) or complex (multiple neuroectodermal lesions). We report this case because the occurrence of retroperitoneal malignant schwannoma arising in a 16-month-old infant born with a pigmented giant nevus is unique, and may represent a previously undescribed form of a complex neurocristopathy. 相似文献
74.
Sonia Ehrlich Tania Bustos Inder J. Paika Aubrey Milunsky John M. Opitz 《American journal of medical genetics. Part A》1983,15(2):261-263
Some variation in the phenotype of patients with dup(18q) is recognized. Our patient has the phenotype described for dup(18qter). 相似文献
75.
Familial partial trisomy 5p resulting from segregation of an insertional translocation 总被引:1,自引:0,他引:1
A case of duplication of segment p13-p15 of the short arm of chromosome 5 as the result of an insertional translocation in a mentally retarded girl with congenital anomalies is reported. Some of the apparently balanced carriers of the inverted insertion showed minor congenital anomalies. 相似文献
76.
Congenital Disorder of Glycosylation (CDG) type Ic is caused by mutations in ALG6. This gene encodes an alpha1,3 glucosyltransferase used for synthesis of the lipid linked oligosaccharide (LLO) precursor of the protein N-glycosylation pathway. CDG-Ic patients have moderate to severe psychomotor retardation, seizures, hypotonia, strabismus, and feeding difficulties. We previously identified a typical patient with a heterozygous point mutation, c.391T>C (p.Tyr131His) in ALG6. Using complementation analysis of ALG6-deficient yeast, we show that this alteration is as severe as the most common disease-causing mutation, c998C>T (p. Ala333Val), which occurs in over half of all known CDG-Ic patients. The frequency of c.391T>C (p.Tyr131His) in the US population, is 0.0214, suggesting that homozygotes would occur at a rate of& tilde;1:2,200. We identified one patient with typical CDG-Ic symptoms and a homozygous p.Tyr131His alteration in ALG6. However, in contrast to most CDG patients, her LLO and plasma transferrin glycosylation appeared normal. Thus, it is unclear whether c.391T>C causes CDG-Ic or contributes to the symptoms. Genotyping additional patients with CDG-like symptoms will be required to resolve this issue. 相似文献
77.
78.
Ricardo A. Maselli Hélio van der Linden Jr Michael Ferns 《American journal of medical genetics. Part A》2020,182(7):1744-1749
Defects in the gene encoding synaptotagmin 2 (SYT2) have been linked to a presynaptic congenital myasthenic syndrome (CMS) and motor neuropathies. However, to date only dominant forms of the disease have been described. We report here a consanguineous patient with a severe recessive form of presynaptic CMS and denervation atrophy caused by the homozygous mutation c.1191delG, p.Arg397Serfs*37 in SYT2. The affected 2‐year‐old girl had profound weakness and areflexia with moderate bulbar deficit. Repetitive nerve stimulation revealed an extreme reduction of compound muscle action potential amplitudes at rest, with a striking facilitation followed by a progressive decline at fast stimulation rates. These findings were reminiscent, but not identical to those seen in the Lambert–Eaton myasthenic syndrome. 3,4 diaminopyridine and pyridostigmine were effective to ameliorate muscle fatigue, but albuterol was ineffective. Modeling of the mutation using the rat Syt1 C2B x‐ray structure revealed that Arg397Serfs*37 disrupts a highly conserved amino acid sequence at the bottom face of the C2B domain not directly involved in calcium binding, but crucial for synaptotagmin‐SNARE interaction and exocytosis. Thus, this report describes a recessive form of synaptotagmin 2‐CMS and highlights the importance of the synaptotagmin C‐terminal on synaptic vesicle fusion and exocytosis. 相似文献
79.
Mersedeh Rohanizadegan Sarah Tracy Carolina I. Galarreta Tabitha Poorvu Terry L. Buchmiller Lynne M. Bird Judy A. Estroff Wen‐Hann Tan 《American journal of medical genetics. Part A》2020,182(8):1890-1895
Esophageal atresia (EA) is a congenital anomaly occurring in 2.3 per 10,000 live births. Due to advances in prenatal imaging, EA is more readily diagnosed, but data on the associated genetic diagnoses, other anomalies, and postnatal outcome for fetuses diagnosed prenatally with EA are scarce. We collected data from two academic medical centers (n = 61). Our data included fetuses with suspected EA on prenatal imaging that was confirmed postnatally and had at least one genetic test. In our cohort of 61 cases, 29 (49%) were born prematurely and 19% of those born alive died in the first 9 years of life. The most commonly associated birth defects were cardiac anomalies (67%) and spine anomalies (50%). A diagnosis was made in 61% of the cases; the most common diagnoses were vertebral defects, anal atresia, cardiac anomalies, tracheoesophageal fistula with esophageal atresia, radial or renal dysplasia, and limb anomalies association (43%, although 12% met only 2 of the criteria), trisomy 21 (5%), and CHARGE syndrome (5%). Our findings suggest that most fetuses with prenatally diagnosed EA have one or more additional major anomaly that warrants a more comprehensive clinical genetics evaluation. Fetuses diagnosed prenatally appear to represent a cohort with a worse outcome. 相似文献
80.